Elena Pezzolo

21PUBLICATIONS
116CO-AUTHORS
AllergyPharmaceutical delivery technologiesEpidemiological methodsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jul 22, 2026
Treatment Outcomes of Lebrikizumab after Switching from Dupilumab in Moderate-to-Severe Atopic Dermatitis involving the Head and Neck Area.

|Apr 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).

Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya

|Nov 07, 2025
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.

Francesca Barei, Paolo Calzari, Stefano Macchi

|Oct 10, 2025
Effectiveness, Safety, and Health-Related Quality of Life in Moderate-to-Severe Atopic Dermatitis Treated with Lebrikizumab: A 16-Week Nationwide Retrospective Cohort Study.

Gianluca Avallone, Andrea Bombelli, Luigi Gargiulo

|Sep 22, 2025
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study.

Luca Bettolini, Stefano Bighetti, Silvia Mariel Ferrucci

|Jul 01, 2025
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review.

Elena Pezzolo, Sara Di Leo, Paola Miceli

Pageof 4

Frequent Collaborators

9 joint publications

Maddalena Napolitano

9 joint publications

Giampiero Girolomoni

8 joint publications

Simone Ribero

7 joint publications

Francesca Barei